HSBC Holdings’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
PVM
NI
HSBC Holdings's HCAT Position: Q2 2026 in Review
HSBC Holdings increased its Health Catalyst (HCAT) stake by 313% in Q2 2026, buying an estimated $447K and bringing the position to 408,634 shares worth $809K. The position accounts for ﹤0.01% of the portfolio, ranked #2052.
HSBC Holdings first reported a position in HCAT in Q2 2021 and has held it in 17 quarters since. The position peaked at $1.39M in Q3 2021. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.
- HSBC Holdings held 408,634 shares of Health Catalyst worth $809K as of Q2 2026.
- HSBC Holdings bought 309,766 Health Catalyst shares in Q2 2026, an estimated $447K.
- Health Catalyst made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2052 holding.
- HSBC Holdings first reported a position in Health Catalyst in Q2 2021 and has held it in 17 quarters since.
- HSBC Holdings's Health Catalyst position peaked at $1.39M in Q3 2021.
- 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.